The Short Answer

Vitamin E can interfere with normal blood clotting processes and may raise bleeding risk when combined with anticoagulant medicines.

That concern is not theoretical. A report in JAMA noted that vitamin E ingestion was associated with coagulopathy and suggested that people with vitamin K deficiency may be at risk of hemorrhage when taking vitamin E (JAMA Network, “Coagulopathy Associated With Vitamin E Ingestion,” 1974).

This matters because anticoagulants intentionally reduce your blood’s ability to form clots. Adding another factor that may impair Coagulation can shift the balance toward easy bruising or clinically significant bleeding.

Important: Do not start, stop, or “double up” vitamin E supplements while on an anticoagulant unless your clinician confirms it is appropriate for you. Seek urgent care for heavy or uncontrolled bleeding, or any signs of internal bleeding.

Why vitamin E can be risky with blood thinners

Vitamin E is a fat-soluble vitamin, and in supplement form it can be taken in doses far above what you would typically get from food.

At higher intakes, vitamin E has been linked to impaired clotting. The JAMA report describing “coagulopathy associated with vitamin E ingestion” concluded that patients with vitamin K deficiency may risk hemorrhage if they take vitamin E (JAMA Network, 1974).

Vitamin K is essential for producing several clotting factors. If vitamin E contributes to a functional vitamin K problem, or worsens an existing deficiency, the combination with an anticoagulant can be particularly concerning.

The practical takeaway is simple. When your medication is designed to reduce clot formation, adding a supplement that may further reduce clotting resilience can increase the likelihood of bleeding complications.

Who should be especially cautious (or avoid it unless cleared)

Some people have less margin for error than others.

Consider extra caution and discuss vitamin E with your clinician first if any of the following apply:

You take warfarin (Coumadin) or another vitamin K sensitive anticoagulant. Warfarin dosing is tightly linked to clotting factor production, so anything that shifts clotting balance can matter, and your INR may need closer monitoring.

You use a direct oral anticoagulant (DOAC) such as apixaban, rivaroxaban, dabigatran, or edoxaban. These do not use INR monitoring in the same way as warfarin, which can make “silent” increases in bleeding tendency harder to spot early.

You have (or might have) low vitamin K status. The JAMA report specifically highlighted hemorrhage risk in the setting of vitamin K deficiency with vitamin E ingestion (JAMA Network, 1974).

You have liver disease, a history of gastrointestinal bleeding, or a bleeding disorder. These conditions can already impair clotting factor production or platelet function, so layering risks is more dangerous.

You are planning a procedure or dental work. Your procedural team often needs a complete list of supplements, since bleeding risk management may change based on everything you take.

Dose and form matter more than most people realize

Food sources of vitamin E (like nuts, seeds, and vegetable oils) generally provide modest amounts and are less likely to create abrupt changes in clotting.

Supplements are different. Many capsules contain high-dose alpha-tocopherol, sometimes hundreds of IU per pill, and people may take them daily for long periods.

The JAMA report linking vitamin E ingestion to coagulopathy is a reminder that “natural” does not equal “risk-free,” particularly when doses exceed typical dietary exposure (JAMA Network, 1974).

If you are taking an anticoagulant, the safest approach is to treat vitamin E like a medication: check the dose, check the label for the exact form, and confirm with a clinician whether it fits your risk profile.

Pro Tip: Bring every supplement bottle (or clear photos of the front and “Supplement Facts” panel) to your anticoagulant follow-up visits. It is much easier for your clinician or pharmacist to assess risk when they can see the exact product and dose.

Warning signs: when to stop and get medical advice

Minor bruising can happen on anticoagulants, but certain symptoms should not be brushed off.

Contact your clinician promptly if you notice new or worsening bleeding symptoms after starting vitamin E, or if bleeding seems harder to stop than usual.

Seek urgent care immediately for symptoms that could signal serious bleeding:

Black, tarry stools or visible blood in stool. This can be a sign of gastrointestinal bleeding and needs prompt evaluation.

Vomiting blood or material that looks like coffee grounds. This can indicate bleeding in the upper GI tract.

Sudden severe headache, weakness, confusion, or vision changes. These can be signs of bleeding in or around the brain.

Heavy menstrual bleeding, nosebleeds that will not stop, or bleeding from gums that is new and persistent. These may indicate an overall shift toward excessive bleeding.

If you are on warfarin, ask whether you should get an INR check sooner. If you are on a DOAC, ask what monitoring or next steps are appropriate, since routine INR testing does not apply.

Key takeaways for safer use

Vitamin E supplements can increase bleeding risk when combined with anticoagulants, and a JAMA report linked vitamin E ingestion to coagulopathy and warned about hemorrhage risk in vitamin K deficiency (JAMA Network, 1974).

Food sources of vitamin E are typically less concerning than high-dose supplements, but you should still tell your clinician about your overall diet and any new supplements.

People at higher risk include those with possible vitamin K deficiency, liver disease, prior GI bleeding, or anyone taking warfarin or a DOAC.

New bruising or bleeding after starting vitamin E is a reason to contact your clinician, and severe symptoms (black stools, vomiting blood, neurologic symptoms) warrant urgent evaluation.